To
Not verified

Topas Therapeutics

What we write about

BiotechnologyIndustriaMedicine - variousPharmaceuticalsScienza
24/04/2025
Eventi
Industria
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Topas Therapeutics Announces Presentation of Phase 2a Data for TPM502 in Celiac Disease at Digestive Disease Week® 2025 in San Diego
1.00
15/10/2024
Industria
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease
1.00

Contact details

Social Media

Followers
0
Compatibility
0